EPIK Biosciences Advances Combination Medicines Across Ketamine-Based and DXM-Based Programs, Supported by 34 Provisional Drug Patent Applications Sep 10, 2026 05:20AM

Over 20 filings are ketamine-based and over 5 are dextromethorphan (DXM)-based; applications total more than 2,700 pages of scientific and technical data; Company expects to disclose the full combination portfolio later this year

AUSTIN, Texas, Sept. 10, 2026 (GLOBE NEWSWIRE) -- EPIK Biosciences (“EPIK” or the “Company”) today announced continued progress as a drug development company advancing proprietary synergistic combination medicines for mental health disorders,... (continue reading...)


Form 8.5 (EPT/RI) - Kore Potash Plc Sep 10, 2026 05:09AM

FORM 8.5 (EPT/RI)

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the “Code”)

1.        KEY INFORMATION

(a)        Name of exempt principal trader:Shore Capital Stockbrokers Ltd(b)        Name of offeror/offeree in relation to whose relevant securities this form relates:         Use a separate form for each offeror/offereeKore Potash Plc(c)        Name of... (continue reading...)
Apex Red FUGA DU 2 celebrates 10th SwissPeaks Trail with Kailas FUGA Sep 10, 2026 05:08AM

SION, Switzerland, Sept. 10, 2026 (GLOBE NEWSWIRE) -- The world’s ultimate glacier-to-lake challenge, SwissPeaks Trail with Kailas FUGA, is celebrating its 10th anniversary with a limited-edition Apex Red FUGA DU 2. Recognised in 2025 by the International Trail Running Association (ITRA) as the ‘highest and longest’ ultramarathon in the world, SwissPeaks Trail signature Odyssey race represents the ultimate fusion of extreme nature and humanity, spanning over 43,800m... (continue reading...)


Form 8.5 (EPT/RI) - CAB Payments Holdings Plc Sep 10, 2026 05:06AM

FORM 8.5 (EPT/RI)

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the “Code”)

1.        KEY INFORMATION

(a)        Name of exempt principal trader:Shore Capital Stockbrokers Ltd(b)        Name of offeror/offeree in relation to whose relevant securities this form relates:         Use a separate form for each offeror/offereeCAB Payments Holdings... (continue reading...)
Form 8.3 - Gamma Communications plc Sep 10, 2026 05:01AM

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)

1.        KEY INFORMATION

(a)   Full name of discloser:Jupiter Fund Management Plc(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and... (continue reading...)

More Globe Newswire

View Older Stories

Sep 10, 2026 05:00AM Federal Labour Code Review underscores the need for new bargaining tools
Sep 10, 2026 05:00AM M&A and Governance
Sep 10, 2026 05:00AM Rackspace Joins NVIDIA Cloud Partner Program, Announces NVIDIA Blackwell-Powered AI Infrastructure for Regulated Enterprises and Governments
Sep 10, 2026 05:00AM Bullhorn named 2027 Salesforce ‘Partner of the Year’ award winner
Sep 10, 2026 05:00AM DFDS APPOINTS NEW CHIEF DIGITAL & INFORMATION OFFICER
Sep 10, 2026 04:59AM Proofpoint Expands AI-Powered Investigations to Microsoft 365 and Deepens Insider Risk Visibility into AI Activity
Sep 10, 2026 04:48AM Dimensional Fund Advisors Ltd. : Form 8.3 - STHREE PLC - Ordinary Shares
Sep 10, 2026 04:45AM Dimensional Fund Advisors Ltd. : Form 8.3 - ROTORK PLC - Ordinary Shares
Sep 10, 2026 04:44AM Dimensional Fund Advisors Ltd. : Form 8.3 - MITIE GROUP PLC - Ordinary Shares
Sep 10, 2026 04:42AM Dimensional Fund Advisors Ltd. : Form 8.3 - Consortium comprising LondonMetric Property plc and Schroder Real Estate Investment Trust Limited
Sep 10, 2026 04:41AM Dimensional Fund Advisors Ltd. : Form 8.3 - CAPRICORN ENERGY PLC - Ordinary Shares
Sep 10, 2026 04:06AM Form 8.3 - [ADVANCED MEDICAL SOLUTIONS GROUP PLC - 09 09 2026] - (CGWL)
Sep 10, 2026 04:04AM Form 8.3 - [APTITUDE SOFTWARE GROUP PLC - 09 09 2026] - (CGAML)
Sep 10, 2026 04:00AM Rakovina Therapeutics Announces Appointment of Professor Petra Hamerlik to its Board of Directors
Sep 10, 2026 04:00AM Aptean Unveils Next-Generation, Cloud-Native, AI-Powered Equipment Dealer Management System
Sep 10, 2026 04:00AM Share Buyback Transaction Details September 3 – September 9, 2026
Sep 10, 2026 03:48AM Completion of conversion of A shares to B shares in accordance with the articles of association and information on adjusted number of voting rights and share capital
Sep 10, 2026 03:44AM UKey Releases Open-Source Firmware for the Core 26 Hardware Wallet
Sep 10, 2026 03:30AM Scenic Biotech Appoints Renowned Neurology Drug Development Leader Dr. Judith Walker as Chief Medical Officer
Sep 10, 2026 03:30AM Teitur Trophics announces successful results from Phase I clinical trial of first-in-class Parkinson’s disease peptide TT-P34
Sep 10, 2026 03:30AM AS Tallink Grupp Managers’ Transactions - Elise Nassar
Sep 10, 2026 03:30AM AS Tallink Grupp Managers' Transcations - Elise Nassar
Sep 10, 2026 03:05AM Introducing Hyceon: A Fully Integrated Pan-European Data Centre Design, Engineering and Advisory Group
Sep 10, 2026 03:00AM CONNECTA Therapeutics Announces Financing to Advance Clinical Development of Fragile X Syndrome Program
Sep 10, 2026 03:00AM Caplin launches end-to-end white-label digital asset solution for institutional trading desks
Sep 10, 2026 03:00AM Caplin launches end-to-end white-label digital asset solution for institutional trading desks
Sep 10, 2026 03:00AM Sage SME Pulse: East Midlands SMEs outpace the UK, offering a blueprint for regional growth
Sep 10, 2026 03:00AM Nokia launches AI and edge platform to help mining and construction industries, public safety, and defense organizations run safer, more resilient field operations
Sep 10, 2026 03:00AM Stabilization Notice - PRE STAB - Derichebourg
Sep 10, 2026 02:55AM Ignitis to enter into a long-term LNG purchase agreement
Sep 10, 2026 02:53AM The consolidated sales of VILVI Group August 2026
Sep 10, 2026 02:43AM New Crypto Coin: Apeing Sells 350M Presale Tokens in Few Hours, Raises $60K+ as ETH Holds Above $2,500 
Sep 10, 2026 02:41AM Recover™ Names Enes Adak and Fehmi Yüksel as Co-CEOs to Accelerate Its Next Growth Phase
Sep 10, 2026 02:38AM Latest News: Apeing’s New Crypto Presale Enters Stage 3 in 6 Hours of Launch at $0.0004 as Bitcoin Trades at $79K
Sep 10, 2026 02:38AM The Grant Room Attracts More Than 4,200 Entrepreneurs Within Two Months of Launch
Sep 10, 2026 02:30AM Zoomex Launches ZWTC 2026 Multi-Asset Trading Championship With a Record Prize Pool of Up to 5 Million USDT
Sep 10, 2026 02:30AM Tec-Do Organized MARS2 Workshop at ECCV 2026 to Advance Multimodal Reasoning for Agentic Commerce
Sep 10, 2026 02:30AM PT Weda Bay Nickel restarts its mining operations
Sep 10, 2026 02:30AM Michelin: Disclosure of trading in own shares - September 10th, 2026
Sep 10, 2026 02:24AM Apeing’s Crypto Presale Goes Parabolic on Launch Day With Over $70k Raised in Hours, While Solana Whales Drop $9.11M
Sep 10, 2026 02:05AM Himax to Showcase Industry-Leading Automotive Display and Cutting-Edge 3D Sensing Technologies at 2026 SID Vehicle Displays and Interfaces Symposium
Sep 10, 2026 02:05AM Tonner Drones Becomes Reference Shareholder of MHM Corporate
Sep 10, 2026 02:00AM Hexiris Ophthalmics to Present First-in-Human OBi Glaucoma Data at Five Fall Meetings, Beginning with the Ophthalmology Futures Forum in London
Sep 10, 2026 02:00AM Holding(s) in Company
Sep 10, 2026 02:00AM Transaction in Own Shares
Sep 10, 2026 02:00AM Sterling Trading Tech Launches STRIDER™
Sep 10, 2026 01:30AM ITV Selects Akamai TrafficPeak to Optimize World Cup Streaming
Sep 10, 2026 01:30AM TomTom and citiEU strengthen ties to deliver advanced traffic monitoring and location analytics solutions
Sep 10, 2026 01:29AM Trifork expands SAP collaboration with new Customer Experience reseller agreement
Sep 10, 2026 01:00AM U.S. FDA grants Priority Review for Roche’s Enspryng for MOGAD, an autoimmune disease with no approved treatments
View Older Stories